New paths in human cancer serology.
作者信息
Old L J, Chen Y T
机构信息
Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.
出版信息
J Exp Med. 1998 Apr 20;187(8):1163-7. doi: 10.1084/jem.187.8.1163.
Abstract
摘要
相似文献
1
New paths in human cancer serology.人类癌症血清学的新路径。
J Exp Med. 1998 Apr 20;187(8):1163-7. doi: 10.1084/jem.187.8.1163.
2
[Identification of tumor antigens: strategies and perspectives].
Dtsch Med Wochenschr. 2006 Aug 18;131(33):1809-12. doi: 10.1055/s-2006-949159.
3
[Identification of tumor antigens: strategies and perspectives].[肿瘤抗原的鉴定：策略与展望]
Praxis (Bern 1994). 2004 Sep 22;93(39):1584-8. doi: 10.1024/0369-8394.93.39.1584.
4
Cancer/testis antigens for therapeutic use.用于治疗的癌胚抗原。
J BUON. 2009 Sep;14 Suppl 1:S97-102.
5
The importance of defining the paraneoplastic neurologic disorders.定义副肿瘤性神经系统疾病的重要性。
N Engl J Med. 1999 Jun 10;340(23):1831-3. doi: 10.1056/NEJM199906103402311.
6
PASD1 is a potential multiple myeloma-associated antigen.
Blood. 2006 Dec 1;108(12):3953-5. doi: 10.1182/blood-2006-04-014621.
7
Antigens shared by rat schwannomas, neuroblastomas, and a testicular interstitial cell carcinoma.
Cancer Res. 1977 Sep;37(9):3379-84.
8
Human tumor immunology at the molecular divide.分子层面的人类肿瘤免疫学
J Immunol. 2007 Mar 1;178(5):2615-6. doi: 10.4049/jimmunol.178.5.2615.
9
Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality.免疫疗法揭示了癌症干细胞耐药性和一种新的合成致死性。
Mol Ther. 2013 Aug;21(8):1472-4. doi: 10.1038/mt.2013.160.
10
Head and neck cancer antigens recognized by the humoral immune system.体液免疫系统识别的头颈癌抗原。
Biochem Biophys Res Commun. 2002 Jun 14;294(3):734-41. doi: 10.1016/S0006-291X(02)00543-0.
引用本文的文献
1
Immunologic specificity in glioblastoma: Antigen discovery and translational implications.胶质母细胞瘤中的免疫特异性：抗原发现及转化意义
Neurooncol Adv. 2025 Sep 9;7(Suppl 4):iv41-iv70. doi: 10.1093/noajnl/vdaf028. eCollection 2025 Sep.
2
Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma.抗 BIRC5 自身抗体可作为诊断 AFP 阴性肝细胞癌的有价值的生物标志物。
PeerJ. 2024 May 31;12:e17494. doi: 10.7717/peerj.17494. eCollection 2024.
3
Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers.癌症/睾丸抗原：消化道肿瘤有前途的免疫治疗靶点。
Front Immunol. 2023 Jun 16;14:1190883. doi: 10.3389/fimmu.2023.1190883. eCollection 2023.
4
Cancer testis antigens and genomic instability: More than immunology.癌症睾丸抗原与基因组不稳定性：超越免疫学。
DNA Repair (Amst). 2021 Dec;108:103214. doi: 10.1016/j.dnarep.2021.103214. Epub 2021 Aug 17.
5
Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma.肿瘤相关抗原（TAAs）在骨肉瘤血清学诊断中的应用。
Front Immunol. 2021 Apr 30;12:665106. doi: 10.3389/fimmu.2021.665106. eCollection 2021.
6
Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer.基于人类蛋白质组芯片鉴定新型自身抗体及其在胃癌检测中的性能评估
Front Oncol. 2021 Feb 26;11:637871. doi: 10.3389/fonc.2021.637871. eCollection 2021.
7
Humoral immune responses: Unsung heroes of the war on cancer.体液免疫反应：抗癌战争中的无名英雄。
Semin Immunol. 2020 Jun;49:101419. doi: 10.1016/j.smim.2020.101419. Epub 2020 Nov 9.
8
Autoantibody Landscape in Patients with Advanced Prostate Cancer.晚期前列腺癌患者的自身抗体全景。
Clin Cancer Res. 2020 Dec 1;26(23):6204-6214. doi: 10.1158/1078-0432.CCR-20-1966. Epub 2020 Sep 23.
9
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process.揭示肿瘤抗原全景：关于发现过程需了解的内容。
Cancers (Basel). 2020 Jun 23;12(6):1660. doi: 10.3390/cancers12061660.
10
The Prognostic Role of CD8 T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss Score.与Ki-67、PD-1、PD-L1及Weiss评分相比，CD8 T淋巴细胞在儿童肾上腺皮质癌中的预后作用
Cancers (Basel). 2019 Nov 5;11(11):1730. doi: 10.3390/cancers11111730.
本文引用的文献
1
Production of embryonal alpha-globulin by transplantable mouse hepatomas.可移植性小鼠肝癌产生胚胎性α-球蛋白
Transplantation. 1963 Apr;1:174-80. doi: 10.1097/00007890-196301020-00004.
2
Characterization of human colon cancer antigens recognized by autologous antibodies.被自身抗体识别的人类结肠癌抗原的特性分析
Int J Cancer. 1998 May 29;76(5):652-8. doi: 10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p.
3
Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28.编码自身免疫原性癌-睾丸抗原NY-ESO-1的基因CTAG的基因组克隆及在人X染色体q28上的定位。
Cytogenet Cell Genet. 1997;79(3-4):237-40. doi: 10.1159/000134734.
4
Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens.鉴定一种减数分裂特异性蛋白为癌胚抗原类的成员。
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5211-6. doi: 10.1073/pnas.95.9.5211.
5
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.一项关于癌症患者对一组人类肿瘤抗原的体液免疫反应的调查。
J Exp Med. 1998 Apr 20;187(8):1349-54. doi: 10.1084/jem.187.8.1349.
6
7
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.针对癌-睾丸抗原NY-ESO-1的体液免疫和细胞免疫反应同时发生：人类组织相容性白细胞抗原（HLA）-A2结合肽表位的定义。
J Exp Med. 1998 Jan 19;187(2):265-70. doi: 10.1084/jem.187.2.265.
8
SSX: a multigene family with several members transcribed in normal testis and human cancer.SSX：一个多基因家族，有几个成员在正常睾丸和人类癌症中被转录。
Int J Cancer. 1997 Sep 17;72(6):965-71. doi: 10.1002/(sici)1097-0215(19970917)72:6<965::aid-ijc8>3.0.co;2-n.
9
Serological identification of human tumor antigens.人类肿瘤抗原的血清学鉴定
Curr Opin Immunol. 1997 Oct;9(5):709-16. doi: 10.1016/s0952-7915(97)80053-2.
10
Serological analysis of human tumor antigens: molecular definition and implications.人类肿瘤抗原的血清学分析：分子定义及意义
Mol Med Today. 1997 Aug;3(8):342-9. doi: 10.1016/s1357-4310(97)01081-2.
Zotero 插件